Current Progress and Future Perspectives of Immune Checkpoint Inhibitors in Biliary Tract Cancer by Seesaha, Poshita-Kumari, Wang, Kang-Xin, Wang, Guo-Qun, Cui, Ting-Yun, Zhao, Feng-Jiao, Pan, Lan-Lan, Li, Xiang-Cheng, Shu, Yong-Qian, Chen, Xiao-Feng

Get full text

Camrelizumab plus gemcitabine and oxaliplatin (GEMOX) in patients with advanced biliary tract cancer: a single-arm, open-label, phase II trial by Chen, Xiaofeng, Wu, Xiaofeng, Wu, Hao, Gu, Yanhong, Shao, Yang, Shao, Qianwen, Zhu, Feipeng, Li, Xiao, Qian, Xiaofeng, Hu, Jun, Zhao, Fengjiao, Mao, Weidong, Sun, Jing, Wang, Jian, Han, Gaohua, Li, Changxian, Xia, Yongxiang, Seesaha, Poshita Kumari, Zhu, Dongqin, Li, Huajun, Zhang, Junling, Wang, Guoqiang, Wang, Xuehao, Li, Xiangcheng, Shu, Yongqian

Get full text

The interplay between dietary factors, gut microbiome and colorectal cancer: a new era of colorectal cancer prevention by Seesaha, Poshita Kumari, Chen, Xiaofeng, Wu, Xiaofeng, Xu, Hongxia, Li, Changxian, Jheengut, Yogesh, Zhao, Fengjiao, Liu, Li, Zhang, Diancai

Get full text

Case fatality rate of the adult in-patients with COVID-19 and digestive system tumors: A systematic review and meta-analysis by Wang, Guoqun, Pan, Lanlan, Zhao, Jianyi, Tang, Jie, Fang, Yueyu, Sun, Hui, Seesaha, Poshita Kumari, Chen, Wensen, Chen, Xiaofeng

Get full text

Olaparib combined with immunotherapy for treating a patient with liver cancer carrying BRCA2 germline mutation: A case report by Zhao, Fengjiao, Zhou, Yong, Seesaha, Poshita Kumari, Zhang, Yihong, Liu, Siqin, Gan, Xiaoyan, Hu, Jun, Gu, Yanhong, Chen, Xiaofeng

Get full text

Case fatality rate of the adult in-patients with COVID-19 and digestive system tumors by Guoqun Wang, MM, Lanlan Pan, MM, Jianyi Zhao, BS, Jie Tang, MM, Yueyu Fang, MM, Hui Sun, MM, Poshita Kumari Seesaha, MM, Wensen Chen, PhD, Xiaofeng Chen, PhD

Get full text